Choosing the Appropriate eTMF Model for Biopharmas

This guide discusses the various trial master file (TMF) operating models suitable for emerging biopharmaceutical companies and biotechs. It outlines the advantages of outsourcing TMF management to contract research organizations (CROs), emphasizing that this partnership can enhance TMF quality while minimizing overhead costs. However, it also highlights the potential risks of limited visibility into TMF content and processes when relying solely on CROs. The document details a hybrid model where both sponsors and CROs manage TMF documents, allowing for greater inspection readiness. It presents best practices for implementing this model, including the importance of collaborative authoring features that facilitate document management between sponsors and CROs. Additionally, the guide addresses the transition to a sponsor-owned eTMF model, discussing the factors influencing this decision, such as trial volume and the need for streamlined processes. It concludes with insights into improving collaboration and oversight in TMF management.